ナノメディシンとナノテクノロジーのジャーナル

概要

Biomarkers, bioinformatics, and nanotechnology coming together to create individualized cancer treatment

Joseph Michael

Biomarker disclosure, Biocomputing, and nanotechnology have raised new open doors for the arising field of customized medication in which sickness identification, analysis, and treatment are custom-made to every individual's sub-atomic profile, and furthermore for prescient medication that utilizes hereditary sub-atomic data to anticipate illness advancement, movement, and clinical result. Multiplexed nanoparticle probes for cancer biomarker profiling and advanced Biocomputing tools for cancer biomarker discovery are the topics of this article, as are the opportunities and challenges associated with tying bio molecular signatures to clinical outcomes. For personalized treatment and molecular diagnosis of cancer and other human diseases, this convergence of bio-nano-information holds great promise.

Keywords

Biomarker disclosure; Biocomputing; Nanotechnology; Sickness analysis. Human diseases; Bio-nano-Information; Clinical outcomes